Abstract
Purpose
Literature supporting the efficacy of complementary and integrative medicine (CIM) alongside radiotherapy is fragmented with varying outcomes and levels of evidence. This review summarizes the available evidence on CIM used with radiotherapy in order to inform clinicians.
Methods
A systematic literature review identified studies on the use of CIM during radiotherapy. Inclusion required the following criteria: the study was interventional, CIM therapy was for human patients with cancer, and CIM therapy was administered concurrently with radiotherapy. Data points of interest were collected from included studies. A subset was identified as high-quality using the Jadad scale. Fisher’s exact test was used to assess the association between study results, outcome measured, and type of CIM.
Results
Overall, 163 articles met inclusion. Of these, 68 (41.7%) were considered high-quality trials. Articles published per year increased over time (p < 0.01). Frequently identified therapies were biologically based therapies (47.9%), mind-body therapies (23.3%), and alternative medical systems (13.5%). Within the subset of high-quality trials, 60.0% of studies reported a favorable change with CIM while 40.0% reported no change. No studies reported an unfavorable change. Commonly assessed outcome types were patient-reported (41.1%) and provider-reported (21.5%). Rate of favorable change did not differ based on type of CIM (p = 0.90) or outcome measured (p = 0.24).
Conclusions
Concurrent CIM may reduce radiotherapy-induced toxicities and improve quality of life, suggesting that physicians should discuss CIM with patients receiving radiotherapy. This review provides a broad overview of investigations on CIM use during radiotherapy and can inform how radiation oncologists advise their patients about CIM.
Similar content being viewed by others
Data availability
All data generated and analyzed during this investigation are available upon request to the corresponding author.
References
Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18(13):2505–2514. https://doi.org/10.1200/JCO.2000.18.13.2505
Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11(3):187–203. https://doi.org/10.1177/1534735411423920
Health NIO (2020) National center for complementary and integrative health
Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 12:1–23
Deng G, Cassileth B (2014) Integrative oncology: an overview. Am Soc Clin Oncol Educ Book 233–242. https://doi.org/10.14694/EdBook_AM.2014.34.233
Lettner S, Kessel KA, Combs SE (2017) Complementary and alternative medicine in radiation oncology: survey of patients’ attitudes. Strahlenther Onkol 193(5):419–425. https://doi.org/10.1007/s00066-017-1101-5
Thomas J, Beinhorn C, Norton D, Richardson M, Sumler SS, Frenkel M (2010) Managing radiation therapy side effects with complementary medicine. J Soc Integr Oncol 8(2):65–80
Moran MS, Ma S, Jagsi R, Yang TJ, Higgins SA, Weidhaas JB, Wilson LD, Lloyd S, Peschel R, Gaudreau B, Rockwell S (2013) A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer. Int J Radiat Oncol Biol Phys 85(1):40–46. https://doi.org/10.1016/j.ijrobp.2012.03.025
Rausch SM, Winegardner F, Kruk KM, Phatak V, Wahner-Roedler DL, Bauer B, Vincent A (2011) Complementary and alternative medicine: use and disclosure in radiation oncology community practice. Support Care Cancer 19(4):521–529. https://doi.org/10.1007/s00520-010-0846-5
Sanford NN, Sher DJ, Ahn C, Aizer AA, Mahal BA (2019) Prevalence and nondisclosure of complementary and alternative medicine use in patients with cancer and cancer survivors in the United States. JAMA Oncol 5(5):735–737. https://doi.org/10.1001/jamaoncol.2019.0349
Ge J, Fishman J, Vapiwala N, Li SQ, Desai K, Xie SX, Mao JJ (2013) Patient-physician communication about complementary and alternative medicine in a radiation oncology setting. Int J Radiat Oncol Biol Phys 85(1):e1–e6. https://doi.org/10.1016/j.ijrobp.2012.08.018
Sparreboom A, Cox MC, Acharya MR, Figg WD (2004) Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 22(12):2489–2503. https://doi.org/10.1200/JCO.2004.08.182
Johnson SB, Park HS, Gross CP, Yu JB (2018) Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers. JAMA Oncol 4(10):1375–1381. https://doi.org/10.1001/jamaoncol.2018.2487
Roter DL, Yost KJ, O’Byrne T, Branda M, Leppin A, Kimball B, Fernandez C, Jatoi A, Kumbamu A, Montori V, Koenig B, Geller G, Larson S, Tilburt J (2016) Communication predictors and consequences of Complementary and Alternative Medicine (CAM) discussions in oncology visits. Patient Educ Couns 99(9):1519–1525. https://doi.org/10.1016/j.pec.2016.06.002
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336–341. https://doi.org/10.1016/j.ijsu.2010.02.007
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12. https://doi.org/10.1016/0197-2456(95)00134-4
Zeng YS, Wang C, Ward KE, Hume AL (2018) Complementary and alternative medicine in hospice and palliative care: a systematic review. J Pain Symptom Manage 56(5):781–794 e784. https://doi.org/10.1016/j.jpainsymman.2018.07.016
Zoungas S, Ninomiya T, Huxley R, Cass A, Jardine M, Gallagher M, Patel A, Vasheghani-Farahani A, Sadigh G, Perkovic V (2009) Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 151(9):631–638. https://doi.org/10.7326/0003-4819-151-9-200911030-00008
Li J, Liu Z, Chen R, Hu D, Li W, Li X, Chen X, Huang B, Liao L (2014) The quality of reports of randomized clinical trials on traditional Chinese medicine treatments: a systematic review of articles indexed in the China National Knowledge Infrastructure database from 2005 to 2012. BMC Complement Altern Med 14:362. https://doi.org/10.1186/1472-6882-14-362
Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP, Morrow GR (2013) Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res 180(1):34–43. https://doi.org/10.1667/RR3255.1
Chen Z, Meng Z, Milbury K, Bei W, Zhang Y, Thornton B, Liao Z, Wei Q, Chen J, Guo X, Liu L, McQuade J, Kirschbaum C, Cohen L (2013) Qigong improves quality of life in women undergoing radiotherapy for breast cancer: results of a randomized controlled trial. Cancer 119(9):1690–1698. https://doi.org/10.1002/cncr.27904
Balk J, Day R, Rosenzweig M, Beriwal S (2009) Pilot, randomized, modified, double-blind, placebo-controlled trial of acupuncture for cancer-related fatigue. J Soc Integr Oncol 7(1):4–11
Ho RT, Fong TC, Cheung IK, Yip PS, Luk MY (2016) Effects of a short-term dance movement therapy program on symptoms and stress in patients with breast cancer undergoing radiotherapy: a randomized, controlled, single-blind trial. J Pain Symptom Manage 51(5):824–831. https://doi.org/10.1016/j.jpainsymman.2015.12.332
Cerchietti LC, Navigante AH, Lutteral MA, Castro MA, Kirchuk R, Bonomi M, Cabalar ME, Roth B, Negretti G, Sheinker B, Uchima P (2006) Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 65(5):1330–1337. https://doi.org/10.1016/j.ijrobp.2006.03.042
Krischer MM, Xu P, Meade CD, Jacobsen PB (2007) Self-administered stress management training in patients undergoing radiotherapy. J Clin Oncol 25(29):4657–4662. https://doi.org/10.1200/JCO.2006.09.0126
Meng Z, Garcia MK, Hu C, Chiang J, Chambers M, Rosenthal DI, Peng H, Zhang Y, Zhao Q, Zhao G, Liu L, Spelman A, Palmer JL, Wei Q, Cohen L (2012) Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma. Cancer 118(13):3337–3344. https://doi.org/10.1002/cncr.26550
O’Callaghan C, Sproston M, Wilkinson K, Willis D, Milner A, Grocke D, Wheeler G (2012) Effect of self-selected music on adults’ anxiety and subjective experiences during initial radiotherapy treatment: a randomised controlled trial and qualitative research. J Med Imaging Radiat Oncol 56(4):473–477. https://doi.org/10.1111/j.1754-9485.2012.02395.x
Yu HM, Liu YF, Cheng YF, Hu LK, Hou M (2008) Effects of rhubarb extract on radiation induced lung toxicity via decreasing transforming growth factor-beta-1 and interleukin-6 in lung cancer patients treated with radiotherapy. Lung Cancer 59(2):219–226. https://doi.org/10.1016/j.lungcan.2007.08.007
Chan CW, Richardson A, Richardson J (2011) Managing symptoms in patients with advanced lung cancer during radiotherapy: results of a psychoeducational randomized controlled trial. J Pain Symptom Manage 41(2):347–357. https://doi.org/10.1016/j.jpainsymman.2010.04.024
Dou YQ, Yang MH, Wei ZM, Xiao C, Yang XH (2010) The study of early application with Dixiong Decoction () for non-small cell lung cancer to decrease the incidence and severity of radiation pneumonitis: a prospective, randomized clinical trial. Chin J Integr Med 16(5):411–416. https://doi.org/10.1007/s11655-010-9998-x
Graham PH, Browne L, Cox H, Graham J (2003) Inhalation aromatherapy during radiotherapy: results of a placebo-controlled double-blind randomized trial. J Clin Oncol 21(12):2372–2376. https://doi.org/10.1200/JCO.2003.10.126
Li GH, Wang DL, Hu YD, Pu P, Li DZ, Wang WD, Zhu B, Hao P, Wang J, Xu XQ, Wan JQ, Zhou YB, Chen ZT (2010) Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy. Med Oncol 27(3):919–925. https://doi.org/10.1007/s12032-009-9307-8
Enblom A, Lekander M, Hammar M, Johnsson A, Onelov E, Ingvar M, Steineck G, Borjeson S (2011) Getting the grip on nonspecific treatment effects: emesis in patients randomized to acupuncture or sham compared to patients receiving standard care. PLoS One 6(3):e14766. https://doi.org/10.1371/journal.pone.0014766
Hejazi J, Rastmanesh R, Taleban FA, Molana SH, Hejazi E, Ehtejab G, Hara N (2016) Effect of curcumin supplementation during radiotherapy on oxidative status of patients with prostate cancer: a double blinded, randomized, placebo-controlled study. Nutr Cancer 68(1):77–85. https://doi.org/10.1080/01635581.2016.1115527
Ben-Josef AM, Chen J, Wileyto P, Doucette A, Bekelman J, Christodouleas J, Deville C, Vapiwala N (2017) Effect of eischens yoga during radiation therapy on prostate cancer patient symptoms and quality of life: a randomized phase II trial. Int J Radiat Oncol Biol Phys 98(5):1036–1044. https://doi.org/10.1016/j.ijrobp.2017.03.043
Merchant TE, Bosley C, Smith J, Baratti P, Pritchard D, Davis T, Li C, Xiong X (2007) A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients. Radiat Oncol 2:45. https://doi.org/10.1186/1748-717X-2-45
Kim SH, Kook JR, Kwon M, Son MH, Ahn SD, Kim YH (2015) The effects of laughter therapy on mood state and self-esteem in cancer patients undergoing radiation therapy: a randomized controlled trial. J Altern Complement Med 21(4):217–222. https://doi.org/10.1089/acm.2014.0152
Wang LJ, Lu JZ, Cai BN, Li MW, Qu BL (2017) Effect of compound Zhuye Shigao Granule ( ) on acute radiation-induced esophagitis in cancer patients: a randomized controlled trial. Chin J Integr Med 23(2):98–104. https://doi.org/10.1007/s11655-016-2652-5
Kirste S, Treier M, Wehrle SJ, Becker G, Abdel-Tawab M, Gerbeth K, Hug MJ, Lubrich B, Grosu AL, Momm F (2011) Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial. Cancer 117(16):3788–3795. https://doi.org/10.1002/cncr.25945
Yun H, Sun L, Mao JJ (2017) Growth of integrative medicine at leading cancer centers between 2009 and 2016: a systematic analysis of NCI-designated comprehensive cancer center websites. J Natl Cancer Inst Monogr 2017(52). https://doi.org/10.1093/jncimonographs/lgx004
King N, Balneaves LG, Levin GT, Nguyen T, Nation JG, Card C, Truant T, Carlson LE (2015) Surveys of cancer patients and cancer health care providers regarding complementary therapy use, communication, and information needs. Integr Cancer Ther 14(6):515–524. https://doi.org/10.1177/1534735415589984
Buckner CA, Lafrenie RM, Denommee JA, Caswell JM, Want DA (2018) Complementary and alternative medicine use in patients before and after a cancer diagnosis. Curr Oncol 25(4):e275–e281. https://doi.org/10.3747/co.25.3884
Beard C, Stason WB, Wang Q, Manola J, Dean-Clower E, Dusek JA, Decristofaro S, Webster A, Doherty-Gilman AM, Rosenthal DS, Benson H (2011) Effects of complementary therapies on clinical outcomes in patients being treated with radiation therapy for prostate cancer. Cancer 117(1):96–102. https://doi.org/10.1002/cncr.25291
Carlson LE, Zelinski E, Toivonen K, Flynn M, Qureshi M, Piedalue KA, Grant R (2017) Mind-body therapies in cancer: what is the latest evidence? Curr Oncol Rep 19(10):67. https://doi.org/10.1007/s11912-017-0626-1
Smith K, Ernst E, Colquhoun D, Sampson W (2016) ‘Complementary & Alternative Medicine’ (CAM): ethical and policy issues. Bioethics 30(2):60–62. https://doi.org/10.1111/bioe.12243
Kaptchuk TJ, Stason WB, Davis RB, Legedza AR, Schnyer RN, Kerr CE, Stone DA, Nam BH, Kirsch I, Goldman RH (2006) Sham device v inert pill: randomised controlled trial of two placebo treatments. BMJ 332(7538):391–397. https://doi.org/10.1136/bmj.38726.603310.55
Mao JJ, Bowman MA, Xie SX, Bruner D, DeMichele A, Farrar JT (2015) Electroacupuncture versus gabapentin for hot flashes among breast cancer survivors: a randomized placebo-controlled trial. J Clin Oncol 33(31):3615–3620. https://doi.org/10.1200/JCO.2015.60.9412
Witt CM, Helmer SM, Schofield P, Wastell M, Canella C, Thomae AV, Rogge AA (2020) Training oncology physicians to advise their patients on complementary and integrative medicine: an implementation study for a manual-guided consultation. Cancer 126(13):3031–3041. https://doi.org/10.1002/cncr.32823
Code availability
Not applicable.
Author information
Authors and Affiliations
Contributions
Conceptualization: Lapen, Cha, Arya, Son, McCall, Golden
Data curation: Lapen, Cha, Huang, Rosenberg, Rooney, McArthur
Formal analysis: Lapen, Rosenberg, Rooney
Writing of manuscript: Lapen, Cha, Huang, Rooney
Revision of Manuscript: Rosenberg, McArthur, Arya, Son, McCall, Golden
Corresponding author
Ethics declarations
Ethics approval
Not applicable as human participants were not involved in this study.
Consent to participate
Not applicable as human participants were not involved in this study.
Consent for publication
Not applicable as human participants were not involved in this study.
Conflict of interest
Dr. Golden reports grant funding from the National Institutes of Health, Radiation Oncology Institute, and Bucksbaum Institute for Clinical Excellence and a financial interest in RadOncQuestions LLC and HemOncReview LLC. All other authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lapen, K., Cha, E., Huang, C.C. et al. The use of complementary and integrative therapies as adjunct interventions during radiotherapy: a systematic review. Support Care Cancer 29, 6201–6209 (2021). https://doi.org/10.1007/s00520-021-06173-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-021-06173-1